ctrl K

Price Alert

ASLAN Pharmaceuticals Lim... (ASLN)

NASDAQ: ASLN · Real-Time Price · USD

0.60

-0.10 (-14.27%)

At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.25M	56.9M	90.17M
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	235.57K	8.59K	494.73K
Other Long-Term Assets	1.72K	8.59M	n/a
Receivables	171.44K	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	2.71M	3.98M	3.61M
Total Current Assets	24.13M	60.88M	93.78M
Property-Plant & Equipment	259.25K	292.74K	232.72K
Goodwill & Intangibles	1.72K	5.84K	9.96K
Total Long-Term Assets	496.53K	307.16K	737.41K
Total Assets	24.63M	61.19M	94.52M
Account Payables	7.92M	12.78M	3.12M
Deferred Revenue	n/a	n/a	2.82M
Short-Term Debt	2.03M	7.96M	199.12K
Other Current Liabilities	3.17M	2.42M	223.35K
Total Current Liabilities	13.11M	23.16M	6.36M
Long-Term Debt	24.8M	29.66M	30.86M
Other Long-Term Liabilities	-24.8M	n/a	n/a
Total Long-Term Liabilities	24.8M	29.66M	30.86M
Total Liabilities	37.91M	52.82M	37.21M
Total Debt	26.83M	37.62M	31.06M
Common Stock	63.93M	63.02M	63.02M
Retained Earnings	-321.07M	-278.39M	-227M
Comprehensive Income	24.07M	-178.95K	-178.95K
Shareholders Equity	-13.29M	8.37M	57.3M
Total Investments	235.57K	8.59K	494.73K